Concepts (225)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Radiography, Interventional | 8 | 2018 | 87 | 2.380 |
Why?
|
| Venous Thrombosis | 9 | 2021 | 182 | 2.110 |
Why?
|
| Catheterization, Central Venous | 4 | 2024 | 132 | 2.050 |
Why?
|
| Thrombolytic Therapy | 7 | 2021 | 204 | 1.590 |
Why?
|
| Ureteral Obstruction | 4 | 2023 | 105 | 1.410 |
Why?
|
| Ultrasonography, Interventional | 7 | 2018 | 193 | 1.140 |
Why?
|
| Tissue Plasminogen Activator | 3 | 2021 | 111 | 1.060 |
Why?
|
| Yttrium Radioisotopes | 3 | 2021 | 18 | 1.020 |
Why?
|
| Radiology, Interventional | 3 | 2022 | 28 | 1.020 |
Why?
|
| Endovascular Procedures | 6 | 2016 | 745 | 0.970 |
Why?
|
| Catheterization, Peripheral | 4 | 2022 | 126 | 0.940 |
Why?
|
| Femoral Vein | 3 | 2024 | 51 | 0.930 |
Why?
|
| Mechanical Thrombolysis | 2 | 2015 | 10 | 0.920 |
Why?
|
| Embolization, Therapeutic | 4 | 2021 | 224 | 0.900 |
Why?
|
| Kidney Transplantation | 2 | 2023 | 638 | 0.840 |
Why?
|
| Vesico-Ureteral Reflux | 1 | 2023 | 81 | 0.780 |
Why?
|
| Ureter | 1 | 2023 | 97 | 0.750 |
Why?
|
| Jugular Veins | 2 | 2020 | 76 | 0.720 |
Why?
|
| Catheters, Indwelling | 2 | 2024 | 156 | 0.720 |
Why?
|
| Child | 35 | 2024 | 24453 | 0.700 |
Why?
|
| Cannula | 1 | 2020 | 28 | 0.700 |
Why?
|
| Device Removal | 2 | 2013 | 222 | 0.690 |
Why?
|
| Central Venous Catheters | 2 | 2022 | 39 | 0.680 |
Why?
|
| Adolescent | 28 | 2024 | 19329 | 0.640 |
Why?
|
| Liver Neoplasms | 5 | 2021 | 1319 | 0.630 |
Why?
|
| Solitary Pulmonary Nodule | 1 | 2018 | 23 | 0.580 |
Why?
|
| Tomography, X-Ray Computed | 4 | 2020 | 2090 | 0.560 |
Why?
|
| Lower Extremity | 2 | 2021 | 187 | 0.550 |
Why?
|
| Carcinoma, Hepatocellular | 3 | 2021 | 938 | 0.550 |
Why?
|
| Extracorporeal Membrane Oxygenation | 2 | 2020 | 628 | 0.540 |
Why?
|
| Stents | 5 | 2024 | 882 | 0.540 |
Why?
|
| Infant | 18 | 2024 | 12482 | 0.530 |
Why?
|
| Medical Errors | 1 | 2018 | 155 | 0.530 |
Why?
|
| Catheter-Related Infections | 1 | 2018 | 130 | 0.520 |
Why?
|
| Fibrinolytic Agents | 2 | 2016 | 199 | 0.520 |
Why?
|
| Child, Preschool | 16 | 2024 | 14050 | 0.520 |
Why?
|
| Pediatrics | 2 | 2018 | 1155 | 0.500 |
Why?
|
| Outpatients | 1 | 2017 | 255 | 0.490 |
Why?
|
| Monitoring, Physiologic | 1 | 2017 | 365 | 0.470 |
Why?
|
| Upper Extremity Deep Vein Thrombosis | 1 | 2014 | 3 | 0.460 |
Why?
|
| Retrospective Studies | 20 | 2024 | 16299 | 0.440 |
Why?
|
| Male | 34 | 2024 | 61283 | 0.420 |
Why?
|
| Ultrasonography | 3 | 2024 | 930 | 0.410 |
Why?
|
| Humans | 50 | 2024 | 124793 | 0.400 |
Why?
|
| Catheterization | 2 | 2011 | 236 | 0.400 |
Why?
|
| Lung Neoplasms | 2 | 2021 | 1604 | 0.390 |
Why?
|
| Vena Cava Filters | 1 | 2011 | 21 | 0.370 |
Why?
|
| Biliary Tract Diseases | 1 | 2010 | 34 | 0.360 |
Why?
|
| Iliac Vein | 2 | 2024 | 34 | 0.350 |
Why?
|
| Female | 31 | 2024 | 66553 | 0.350 |
Why?
|
| Veins | 1 | 2011 | 107 | 0.350 |
Why?
|
| Venous Thromboembolism | 2 | 2024 | 165 | 0.350 |
Why?
|
| Liver | 1 | 2017 | 1764 | 0.340 |
Why?
|
| Infant, Newborn | 8 | 2018 | 8182 | 0.330 |
Why?
|
| Punctures | 4 | 2024 | 55 | 0.330 |
Why?
|
| Treatment Outcome | 15 | 2024 | 12342 | 0.320 |
Why?
|
| Lymphatic Diseases | 1 | 2009 | 31 | 0.320 |
Why?
|
| Popliteal Artery | 1 | 2009 | 54 | 0.310 |
Why?
|
| Pulmonary Embolism | 1 | 2011 | 178 | 0.310 |
Why?
|
| Intermittent Claudication | 1 | 2009 | 58 | 0.310 |
Why?
|
| Angiography, Digital Subtraction | 4 | 2020 | 51 | 0.300 |
Why?
|
| Vena Cava, Inferior | 2 | 2021 | 103 | 0.300 |
Why?
|
| Arachnoid Cysts | 1 | 2007 | 8 | 0.280 |
Why?
|
| Nephrolithiasis | 2 | 2018 | 14 | 0.280 |
Why?
|
| Epidermal Cyst | 1 | 2007 | 19 | 0.280 |
Why?
|
| Spinal Cord Diseases | 1 | 2007 | 41 | 0.270 |
Why?
|
| Postoperative Complications | 2 | 2021 | 3068 | 0.270 |
Why?
|
| Portal Vein | 2 | 2017 | 92 | 0.270 |
Why?
|
| Cysts | 2 | 2024 | 101 | 0.260 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2007 | 142 | 0.260 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2009 | 3587 | 0.250 |
Why?
|
| Vascular Surgical Procedures | 1 | 2011 | 578 | 0.250 |
Why?
|
| Urography | 1 | 2005 | 31 | 0.250 |
Why?
|
| Radiation Dosage | 3 | 2015 | 135 | 0.250 |
Why?
|
| Practice Guidelines as Topic | 2 | 2013 | 1265 | 0.240 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 2 | 2015 | 50 | 0.240 |
Why?
|
| Time Factors | 6 | 2017 | 6309 | 0.240 |
Why?
|
| Urologic Diseases | 1 | 2005 | 45 | 0.240 |
Why?
|
| Head and Neck Neoplasms | 1 | 2009 | 498 | 0.230 |
Why?
|
| Anticoagulants | 4 | 2022 | 592 | 0.210 |
Why?
|
| Liver Transplantation | 2 | 2016 | 1038 | 0.210 |
Why?
|
| Muscle, Skeletal | 1 | 2009 | 954 | 0.200 |
Why?
|
| Models, Animal | 2 | 2014 | 465 | 0.190 |
Why?
|
| Constriction, Pathologic | 1 | 2023 | 243 | 0.190 |
Why?
|
| May-Thurner Syndrome | 1 | 2021 | 4 | 0.190 |
Why?
|
| Giant Cell Tumor of Bone | 1 | 2021 | 6 | 0.180 |
Why?
|
| Denosumab | 1 | 2021 | 13 | 0.180 |
Why?
|
| Bone Density Conservation Agents | 1 | 2021 | 52 | 0.180 |
Why?
|
| Renal Artery Obstruction | 1 | 2020 | 41 | 0.170 |
Why?
|
| Lymphangioma | 1 | 2020 | 22 | 0.170 |
Why?
|
| Lymphatic Vessels | 1 | 2020 | 37 | 0.170 |
Why?
|
| Phlebography | 3 | 2016 | 50 | 0.170 |
Why?
|
| Teratoma | 1 | 2021 | 123 | 0.170 |
Why?
|
| Fluoroscopy | 2 | 2017 | 91 | 0.160 |
Why?
|
| Nephrostomy, Percutaneous | 2 | 2017 | 19 | 0.160 |
Why?
|
| Drainage | 2 | 2011 | 258 | 0.160 |
Why?
|
| Femoral Artery | 1 | 2020 | 194 | 0.160 |
Why?
|
| Young Adult | 7 | 2021 | 8987 | 0.160 |
Why?
|
| Hepatoblastoma | 1 | 2021 | 180 | 0.160 |
Why?
|
| Radiographic Image Enhancement | 2 | 2015 | 41 | 0.150 |
Why?
|
| Fused Kidney | 1 | 2018 | 3 | 0.150 |
Why?
|
| Muscular Atrophy, Spinal | 1 | 2018 | 44 | 0.150 |
Why?
|
| Oligonucleotides | 1 | 2018 | 89 | 0.150 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2021 | 1135 | 0.150 |
Why?
|
| Methylene Blue | 1 | 2018 | 13 | 0.150 |
Why?
|
| Feasibility Studies | 3 | 2016 | 762 | 0.140 |
Why?
|
| Thoracic Surgery, Video-Assisted | 1 | 2018 | 53 | 0.140 |
Why?
|
| Iatrogenic Disease | 1 | 2018 | 132 | 0.140 |
Why?
|
| Ureterostomy | 1 | 2017 | 6 | 0.140 |
Why?
|
| Kidney Pelvis | 1 | 2017 | 44 | 0.140 |
Why?
|
| Splenic Artery | 1 | 2017 | 26 | 0.140 |
Why?
|
| Patient Care Planning | 1 | 2018 | 122 | 0.140 |
Why?
|
| Dwarfism | 1 | 2018 | 100 | 0.140 |
Why?
|
| Thrombosis | 1 | 2022 | 521 | 0.140 |
Why?
|
| Ovarian Neoplasms | 1 | 2021 | 418 | 0.140 |
Why?
|
| Image-Guided Biopsy | 1 | 2017 | 37 | 0.140 |
Why?
|
| Thrombectomy | 2 | 2014 | 103 | 0.140 |
Why?
|
| Sensitivity and Specificity | 5 | 2020 | 2044 | 0.130 |
Why?
|
| Biopsy, Needle | 1 | 2017 | 229 | 0.130 |
Why?
|
| Portasystemic Shunt, Transjugular Intrahepatic | 1 | 2016 | 18 | 0.130 |
Why?
|
| Bone Neoplasms | 1 | 2021 | 429 | 0.130 |
Why?
|
| Equipment Design | 3 | 2013 | 600 | 0.130 |
Why?
|
| Equipment Failure Analysis | 2 | 2013 | 86 | 0.130 |
Why?
|
| Liver Cirrhosis, Biliary | 1 | 2016 | 75 | 0.130 |
Why?
|
| Cone-Beam Computed Tomography | 1 | 2015 | 17 | 0.130 |
Why?
|
| Lithotripsy | 1 | 2015 | 22 | 0.130 |
Why?
|
| Esophageal and Gastric Varices | 1 | 2016 | 64 | 0.130 |
Why?
|
| Hypertension, Portal | 1 | 2016 | 78 | 0.120 |
Why?
|
| Urogenital Abnormalities | 1 | 2017 | 156 | 0.120 |
Why?
|
| Anesthesia | 1 | 2018 | 211 | 0.120 |
Why?
|
| Prognosis | 2 | 2021 | 4607 | 0.120 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2015 | 60 | 0.120 |
Why?
|
| Microcephaly | 1 | 2018 | 332 | 0.120 |
Why?
|
| Radiation Protection | 1 | 2014 | 54 | 0.110 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2016 | 225 | 0.110 |
Why?
|
| Radiation Monitoring | 1 | 2013 | 13 | 0.110 |
Why?
|
| Combined Modality Therapy | 2 | 2014 | 1247 | 0.110 |
Why?
|
| Hemorrhage | 1 | 2017 | 466 | 0.110 |
Why?
|
| Robotic Surgical Procedures | 1 | 2017 | 201 | 0.110 |
Why?
|
| X-Ray Intensifying Screens | 1 | 2013 | 2 | 0.110 |
Why?
|
| Vascular Patency | 1 | 2014 | 213 | 0.110 |
Why?
|
| Adenoma, Liver Cell | 1 | 2013 | 4 | 0.110 |
Why?
|
| Liver Diseases | 1 | 2017 | 366 | 0.110 |
Why?
|
| Iodine | 1 | 2013 | 24 | 0.110 |
Why?
|
| Kidney | 1 | 2020 | 1354 | 0.110 |
Why?
|
| Angiography | 2 | 2015 | 217 | 0.100 |
Why?
|
| Medical Staff, Hospital | 1 | 2013 | 92 | 0.100 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2015 | 368 | 0.100 |
Why?
|
| Syndrome | 2 | 2021 | 1118 | 0.100 |
Why?
|
| Infusions, Intravenous | 1 | 2014 | 549 | 0.100 |
Why?
|
| Angioplasty, Balloon | 1 | 2014 | 168 | 0.100 |
Why?
|
| Contrast Media | 3 | 2020 | 471 | 0.100 |
Why?
|
| Gadolinium | 1 | 2013 | 104 | 0.100 |
Why?
|
| Occupational Exposure | 1 | 2013 | 129 | 0.100 |
Why?
|
| Hospitals, Pediatric | 2 | 2016 | 775 | 0.100 |
Why?
|
| Laparoscopy | 1 | 2017 | 490 | 0.100 |
Why?
|
| Brachytherapy | 1 | 2012 | 75 | 0.100 |
Why?
|
| Atrioventricular Block | 1 | 2012 | 39 | 0.100 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2017 | 963 | 0.100 |
Why?
|
| Upper Extremity | 1 | 2012 | 53 | 0.100 |
Why?
|
| Age Factors | 2 | 2016 | 2817 | 0.090 |
Why?
|
| Abdominal Abscess | 1 | 2011 | 24 | 0.090 |
Why?
|
| Cholangiography | 1 | 2010 | 14 | 0.090 |
Why?
|
| Biliary Tract | 1 | 2010 | 15 | 0.090 |
Why?
|
| Dilatation | 1 | 2011 | 66 | 0.090 |
Why?
|
| Diagnostic Imaging | 1 | 2012 | 277 | 0.090 |
Why?
|
| Catheter Ablation | 1 | 2013 | 238 | 0.090 |
Why?
|
| Heart | 1 | 2015 | 724 | 0.090 |
Why?
|
| Catheters | 1 | 2011 | 87 | 0.090 |
Why?
|
| Pacemaker, Artificial | 1 | 2012 | 176 | 0.080 |
Why?
|
| Head | 1 | 2009 | 103 | 0.080 |
Why?
|
| Risk Factors | 2 | 2014 | 10272 | 0.080 |
Why?
|
| Neck | 1 | 2009 | 137 | 0.070 |
Why?
|
| Lymphatic Metastasis | 1 | 2009 | 410 | 0.070 |
Why?
|
| Cohort Studies | 1 | 2017 | 4783 | 0.070 |
Why?
|
| Lymph Nodes | 1 | 2009 | 380 | 0.070 |
Why?
|
| Recurrence | 2 | 2024 | 1425 | 0.070 |
Why?
|
| Follow-Up Studies | 2 | 2017 | 5153 | 0.070 |
Why?
|
| Prospective Studies | 3 | 2022 | 6137 | 0.060 |
Why?
|
| Gadolinium DTPA | 1 | 2005 | 48 | 0.060 |
Why?
|
| Angioplasty | 2 | 2016 | 87 | 0.060 |
Why?
|
| Reproducibility of Results | 3 | 2015 | 2880 | 0.050 |
Why?
|
| Ohio | 2 | 2013 | 86 | 0.050 |
Why?
|
| Adult | 5 | 2021 | 29471 | 0.050 |
Why?
|
| Diagnosis, Differential | 1 | 2007 | 1893 | 0.050 |
Why?
|
| Swine | 2 | 2015 | 1173 | 0.050 |
Why?
|
| Hepatectomy | 1 | 2021 | 110 | 0.040 |
Why?
|
| Lymphatic System | 1 | 2020 | 20 | 0.040 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2021 | 356 | 0.040 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2020 | 161 | 0.040 |
Why?
|
| Computed Tomography Angiography | 1 | 2020 | 198 | 0.040 |
Why?
|
| Consensus | 1 | 2022 | 634 | 0.040 |
Why?
|
| Nephrolithotomy, Percutaneous | 1 | 2018 | 4 | 0.040 |
Why?
|
| Risk Assessment | 2 | 2017 | 3435 | 0.040 |
Why?
|
| Disease Management | 1 | 2021 | 521 | 0.030 |
Why?
|
| Portography | 1 | 2016 | 1 | 0.030 |
Why?
|
| Portal Pressure | 1 | 2016 | 5 | 0.030 |
Why?
|
| Fatty Liver | 1 | 2018 | 184 | 0.030 |
Why?
|
| Disease-Free Survival | 1 | 2018 | 868 | 0.030 |
Why?
|
| Postthrombotic Syndrome | 1 | 2016 | 2 | 0.030 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2017 | 201 | 0.030 |
Why?
|
| Retreatment | 1 | 2016 | 88 | 0.030 |
Why?
|
| X-Rays | 1 | 2015 | 27 | 0.030 |
Why?
|
| Needles | 1 | 2015 | 51 | 0.030 |
Why?
|
| Scattering, Radiation | 1 | 2015 | 50 | 0.030 |
Why?
|
| Risk | 1 | 2017 | 757 | 0.030 |
Why?
|
| Tertiary Care Centers | 1 | 2016 | 236 | 0.030 |
Why?
|
| Phantoms, Imaging | 1 | 2015 | 131 | 0.030 |
Why?
|
| Occupational Injuries | 1 | 2013 | 10 | 0.030 |
Why?
|
| Wireless Technology | 1 | 2013 | 11 | 0.030 |
Why?
|
| Survival Rate | 1 | 2018 | 2035 | 0.030 |
Why?
|
| Aged | 2 | 2016 | 19691 | 0.030 |
Why?
|
| Animals | 4 | 2015 | 34184 | 0.030 |
Why?
|
| Feedback | 1 | 2013 | 164 | 0.030 |
Why?
|
| Subclavian Vein | 1 | 2012 | 23 | 0.030 |
Why?
|
| Rabbits | 1 | 2013 | 711 | 0.020 |
Why?
|
| Radiation Injuries | 1 | 2013 | 143 | 0.020 |
Why?
|
| Radiopharmaceuticals | 1 | 2012 | 160 | 0.020 |
Why?
|
| Middle Aged | 2 | 2016 | 26716 | 0.020 |
Why?
|
| Guideline Adherence | 1 | 2013 | 382 | 0.020 |
Why?
|
| Pelvis | 1 | 2011 | 71 | 0.020 |
Why?
|
| Rectum | 1 | 2011 | 99 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2013 | 1691 | 0.020 |
Why?
|
| Pregnancy | 1 | 2017 | 7172 | 0.010 |
Why?
|
| United States | 1 | 2016 | 10885 | 0.010 |
Why?
|